Indravadan Ambalal Modi, chairman, Cadila Pharmaceuticals has been conferred with "Lifetime Achievement Award''''02" by Pharma Business & Technology, Mumbai.

Being a first generation, Technocrat Entrepreneur of Independent India, the award criteria well suited the profile of I.A. Modi who had played a significant role in shaping up the Indian Pharma Industry, along with his own brain child Cadila. Be it, building brands, competitiveness in succeeding in a challenging environment, general welfare of customers, individual influence to peer group and society or building an ethical organization, Modi''''s contributions are well applauded.

Beginning as a start-up enterprise in 1951, Cadila over the last fifty years has contributed significantly to the Indian Pharmaceutical Industry. Amongst the many first novel formulations introduced by Cadila Pharmaceuticals include India''''s first indigenous Streptokinase, ''''STpase'''', a rapid HIV Diagnostic Kit - NEVA-HIV, world''''s first Sparfloxacin eyedrop `SCAT'''' and Immuvac, a unique immunomodulator. Today, Cadila Pharmaceuticals is amongst the front-runners of the Industry having formidable presence in more than 45 countries and owning offices and subsidiaries in Russia, Africa, Americas and Japan. A leading player back at home, Cadila Pharmaceuticals under the aegis of I.A. Modi is all geared up for a quantum leap in the world''''s most regulated markets as well, during the post GATT era.

Modi received the Lifetime Achievement Award, comprising a plaque and a citation at the hands of Digvijay Khanvilkar, Hon''''ble Health Minister of Maharashtra at a glittering function well attended by the Medical Fraternity and Industry leaders at Hotel Ramda Palm Grove, Mumbai on September 21, 2002.